Two Sigma Advisers’s Immunogen Inc IMGN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-523,118
Closed -$15.5M 2703
2023
Q4
$15.5M Sell
523,118
-771,400
-60% -$22.9M 0.04% 394
2023
Q3
$20.5M Buy
1,294,518
+108,400
+9% +$1.72M 0.05% 305
2023
Q2
$22.4M Sell
1,186,118
-1,744,500
-60% -$32.9M 0.06% 285
2023
Q1
$11.3M Sell
2,930,618
-348,500
-11% -$1.34M 0.03% 517
2022
Q4
$16.3M Buy
3,279,118
+266,700
+9% +$1.32M 0.05% 390
2022
Q3
$14.4M Buy
3,012,418
+185,600
+7% +$887K 0.04% 397
2022
Q2
$12.7M Buy
2,826,818
+364,900
+15% +$1.64M 0.04% 446
2022
Q1
$11.7M Buy
2,461,918
+301,600
+14% +$1.44M 0.03% 457
2021
Q4
$16M Buy
2,160,318
+12,596
+0.6% +$93.5K 0.04% 363
2021
Q3
$12.2M Sell
2,147,722
-826,596
-28% -$4.69M 0.03% 454
2021
Q2
$19.6M Buy
2,974,318
+26,400
+0.9% +$174K 0.05% 339
2021
Q1
$23.9M Buy
2,947,918
+310,000
+12% +$2.51M 0.07% 322
2020
Q4
$17M Buy
2,637,918
+649,100
+33% +$4.19M 0.05% 391
2020
Q3
$7.16M Buy
1,988,818
+885,200
+80% +$3.19M 0.02% 632
2020
Q2
$5.08M Buy
1,103,618
+99,600
+10% +$458K 0.01% 787
2020
Q1
$3.42M Buy
1,004,018
+351,700
+54% +$1.2M 0.01% 863
2019
Q4
$3.33M Buy
652,318
+133,500
+26% +$682K 0.01% 1001
2019
Q3
$1.26M Buy
518,818
+29,100
+6% +$70.4K ﹤0.01% 1335
2019
Q2
$1.06M Buy
489,718
+103,500
+27% +$225K ﹤0.01% 1488
2019
Q1
$1.05M Buy
386,218
+179,700
+87% +$487K ﹤0.01% 1509
2018
Q4
$991K Buy
206,518
+113,384
+122% +$544K ﹤0.01% 1482
2018
Q3
$882K Sell
93,134
-224,500
-71% -$2.13M ﹤0.01% 1553
2018
Q2
$3.09M Sell
317,634
-366,818
-54% -$3.57M 0.01% 1084
2018
Q1
$7.2M Buy
684,452
+90,900
+15% +$956K 0.02% 709
2017
Q4
$3.81M Buy
+593,552
New +$3.81M 0.01% 955
2017
Q1
Sell
-32,052
Closed -$65K 2500
2016
Q4
$65K Sell
32,052
-7,000
-18% -$14.2K ﹤0.01% 2292
2016
Q3
$105K Sell
39,052
-113,966
-74% -$306K ﹤0.01% 2132
2016
Q2
$471K Buy
+153,018
New +$471K ﹤0.01% 1546
2015
Q4
Sell
-18,618
Closed -$179K 2058
2015
Q3
$179K Buy
18,618
+2,900
+18% +$27.9K ﹤0.01% 1661
2015
Q2
$226K Buy
+15,718
New +$226K ﹤0.01% 1711